1. |
Farges O, Kalil AN, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation, 1995, 59(8): 1124-1133.
|
2. |
Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet, 1990, 336(8714): 519-523.
|
3. |
Lo CM, Shaked A, Busuttil RW. Risk factors for liver transplantation across the ABO barrier. Transplantation, 1994, 58(5): 543-547.
|
4. |
Urbani L, Mazzoni A, Bianco I, et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher, 2008, 23(2): 55-62.
|
5. |
Ikegami T, Taketomi A, Soejima Y, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Transplantation, 2009, 88(3): 303-307.
|
6. |
Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology, 2008, 47(1): 143-152.
|
7. |
Kim JD, Choi DL, Kim SG, et al. Single-center experience of ABO-incompatible living-donor liver transplantation with a new simplified intravenous immunoglobulin protocol: A propensity score-matching analysis. Transplant Proc, 2016, 48(4): 1134-1138.
|
8. |
金磊, 殷浩, 傅宏, 等. 跨血型肝移植26例经验. 中华肝胆外科杂志, 2014, 20(10): 705-709.
|
9. |
Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med, 2001, 345(10): 747-755.
|
10. |
Watanabe J, Scornik JC. IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity. Am J Transplant, 2005, 5(11): 2786-2790.
|
11. |
Basta M, Van Goor F, Luccioli S, et al. F(ab)′ 2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med, 2003, 9(4): 431-438.
|
12. |
Jordan SC, Vo A, Tyan D, et al. Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. Trans Am Clin Climatol Assoc, 2006, 117: 199-211.
|
13. |
Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 2001, 291(5503): 484-486.
|
14. |
Kim JD, Choi DL, Han YS. Fourteen successful consecutive cases of ABO-incompatible living donor liver transplantation: new simplified intravenous immunoglobulin protocol without local infusion therapy. Transplant Proc, 2014, 46(3): 754-757.
|
15. |
Gelfand EW. Critical decisions in selecting an intravenous immunoglobulin product. J Infus Nurs, 2005, 28(6): 366-374.
|
16. |
Welsh KJ, Bai Y. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications. J Clin Apher, 2015, 30(6): 371-374.
|
17. |
Shen T, Lin BY, Jia JJ, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. Hepatobiliary Pancreat Dis Int, 2014, 13(4): 395-401.
|
18. |
Lee CF, Cheng CH, Wang YC, et al. Adult living donor liver transplantation across ABO-incompatibility. Medicine (Baltimore), 2015, 94(42): e1796.
|
19. |
Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant, 2014, 14(1): 102-114.
|
20. |
Ikegami T, Yoshizumi T, Soejima Y, et al. Feasible usage of ABO incompatible grafts in living donor liver transplantation. Hepatobiliary Surg Nutr, 2016, 5(2): 91-97.
|
21. |
Yoon YI, Song GW, Lee SG, et al. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma. J Hepatol, 2018, 68(6): 1153-1162.
|
22. |
Kim SH, Lee EC, Shim JR, et al. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation. Liver Int, 2018, 38(5): 932-939.
|
23. |
Lee J, Lee JG, Lee JJ, et al. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution. Transplant Proc, 2015, 47(3): 723-726.
|
24. |
Yadav DK, Hua YF, Bai X, et al. ABO-incompatible adult living donor liver transplantation in the era of rituximab: A systematic review and meta-analysis. Gastroenterol Res Pract, 2019, 2019: 8589402.
|
25. |
Mysore KR, Himes RW, Rana A, et al. ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes. Pediatr Transplant, 2018, 22(7): e13263.
|